Zazulina, O. V.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

Pasi A Jänne, Alice T Shaw, José Rodrigues Pereira, Gaëlle Jeannin, Johan Vansteenkiste, Carlos Barrios, Fabio Andre Franke, Lynda Grinsted, Victoria Zazulina, Paul Smith, Ian Smith, Lucio Crinò

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 336 KB

english, 2013

2

Fibre from a mixture of polyacrylonitrile and polymethyl acrylate

S. B. Krasovskaya, Z. A. Zazulina, A. A. Konkin

Journal:

Fibre Chemistry

Year:

1970

Language:

english

File:

PDF, 257 KB

english, 1970

3

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors

Suzanne Leijen, Patricia M. M. B. Soetekouw, T. R. Jeffry Evans, Marianne Nicolson, Jan H. M. Schellens, Maria Learoyd, Lynda Grinsted, Victoria Zazulina, Thinn Pwint, Mark Middleton

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 303 KB

english, 2011

4

Effect of SiC substrate properties on structural perfection and electrical parameters of AlGaN/GaN layers

Enisherlova, Kira L., Rusak, Tatyana F., Korneev, Vyacheslav I., Zazulina, A.N.

Journal:

Modern Electronic Materials

Year:

2017

Language:

english

File:

PDF, 1.54 MB

english, 2017

5

Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A)

Wu, Y., Geater, S.L., Mok, T., O'Byrne, K.J., Schuler, M.H., Sequist, L.V., Yang, J.C., Massey, D., O’Brien, D., Zazulina, V.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 57 KB

english, 2014

6

69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7

O'Byrne, K.J., Park, K., Tan, E., Zhang, L., Hirsh, V., Boyer, M., Yang, J.C., Mok, T., Kim, M., Massey, D., Zazulina, V., Paz-Ares, L.

Journal:

Year:

2016

Language:

english

File:

PDF, 58 KB

english, 2016

7

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma

Kirkwood, J. M., Bastholt, L., Robert, C., Sosman, J., Larkin, J., Hersey, P., Middleton, M., Cantarini, M., Zazulina, V., Kemsley, K., Dummer, R.

Journal:

Clinical Cancer Research

Year:

2012

Language:

english

File:

PDF, 374 KB

english, 2012

8

Investigation of precious metal inclusions in highly carbonaceous rocks by the SEM and X-Ray spectrum analysis methods

N. V. Berdnikov, N. S. Konovalova, V. Ye. Zazulina

Journal:

Russian Journal of Pacific Geology

Year:

2010

Language:

english

File:

PDF, 359 KB

english, 2010

9

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations

Yang, J. C.-H., Hirsh, V., Schuler, M., Yamamoto, N., O'Byrne, K. J., Mok, T. S. K., Zazulina, V., Shahidi, M., Lungershausen, J., Massey, D., Palmer, M., Sequist, L. V.

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 360 KB

english, 2013

10

Synthesis of nitrogen-containing derivatives of 17(20)-pregnenoic, 17β-hydroxypregnanoic, and 17α-hydroxypregnanoic acids as new potential antiandrogens

Zolottsev, V. A., Kostin, V. A., Novikov, R. A., Tkachev, Ya. V., Zavialova, M. G., Taratynova, M. O., Latysheva, A. S., Zazulina, O. V., Timofeev, V. P., Misharin, A. Yu.

Journal:

Russian Chemical Bulletin

Year:

2018

Language:

english

File:

PDF, 1.10 MB

english, 2018

11

356 INVITED Big Pharma: Competitors or Collaborators?

V. Zazulina, J. Ryan, K. Shannon, L. Yan

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 39 KB

english, 2011

12

Fibre spinning from a mixture of polyacrylonitrile with polyurethane

S. Krasovskaya, A. Konkin, Z. Zazulina

Journal:

Fibre Chemistry

Year:

1971

Language:

english

File:

PDF, 108 KB

english, 1971

13

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

Schuler, Martin, Wu, Yi-Long, Hirsh, Vera, O’Byrne, Kenneth, Yamamoto, Nobuyuki, Mok, Tony, Popat, Sanjay, Sequist, Lecia V., Massey, Dan, Zazulina, Victoria, Yang, James C.-H.

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 1.31 MB

english, 2016

14

Activity of Afatinib in Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations in Lux-Lung 3, A Phase III Trial of Afatinib or Cisplatin/Pemetrexed in EGFR Mutation-Positive Lung Cancer

Yang, J.C., Schuler, M., Yamamoto, N., O'Byrne, K.J., Hirsh, V., Mok, T.S.K., Massey, D., Zazulina, V., Shahidi, M., Sequist, L.V.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 80 KB

2012

15

Lux-Lung 3: Afatinib Versus Cisplatin and Pemetrexed in Japanese Patients with Adenocarcinoma of the Lung Harboring an EGFR Mutation

Yamamoto, N., Schuler, M., O'Byrne, K., Hirsh, V., Mok, T., Kato, T., Yoshioka, H., Okamoto, I., Yokoyama, A, Massey, D., Jones, H., Zazulina, V., Shahidi, M., Sequist, L., Yang, J.C.-H.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 52 KB

2012

16

Overall Survival (OS) With Afatinib Versus Chemotherapy in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Common (Del19/L858R) Epidermal Growth Factor Receptor Mutations (EGFR Mut): Results of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)

Sequist, L., Wu, Y., Schuler, M., O'Byrne, K., Sebastian, M., Popat, S., Boyer, M., Mok, T., Yamamoto, N., Hirsh, V., Geater, S.L., Zhou, C., Massey, D., Zazulina, V., Jones, H., Yang, J.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 79 KB

english, 2014

17

Conjugates of 17-substituted testosterone and epitestosterone with pyropheophorbide a differing in the length of linkers

Zolottsev, Vladimir A., Ponomarev, Gelii V., Taratynova, Maria O., Morozevich, Galina E., Novikov, Roman A., Timofeev, Vladimir P., Solyev, Pavel N., Zavialova, Maria G., Zazulina, Olga V., Tkachev, Y

Journal:

Year:

2018

Language:

english

File:

PDF, 1.16 MB

english, 2018

18

Erratum

Sequist, L., Wu, Y., Schuler, M., O'Byrne, K., Sebastian, M., Popat, S., Boyer, M., Mok, T., Yamamoto, N., Hirsh, V., Geater, S.L., Zhou, C., Massey, D., Zazulina, V., Jones, H., Yang, J.

Journal:

Proceedings of the IRE

Year:

1928

Language:

english

File:

PDF, 98 KB

english, 1928

19

AMLODIPINE AND VALSARTAN SINGLE PILL COMBINATION EFFICACY AND SAFETY IN TREATMENT OF ARTERIAL HYPERTENSION IN REAL LIFE PRACTICE IN RUSSIA

Chazova, I., Karpov, Y., Vigdorchik, A., Zazulina, A.

Journal:

Journal of Hypertension

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

20

445POverall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut): Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)

Wu, Y.-L., Sequist, L.V., Schuler, M., Yamamoto, N., Zhou, C., Hu, C.-P., O'Byrne, K., Hirsh, V., Mok, T., Zazulina, V., Yang, J.C.-H.

Journal:

Annals of Oncology

Year:

2015

Language:

english

File:

PDF, 38 KB

english, 2015

21

LBA2_PRAfatinib (A) vs gefitinib (G) as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring activating EGFR mutations: results of the global, randomized, open-label, Phase IIb trial LUX-Lung 7 (LL7)

Park, K., Tan, E.-H., Zhang, L., Hirsh, V., O'Byrne, K., Boyer, M., Yang, J.C.-H., Mok, T., Kim, M., Massey, D., Zazulina, V., Paz-Ares, L.

Journal:

Annals of Oncology

Year:

2015

Language:

english

File:

PDF, 39 KB

english, 2015

22

LUX-lung 3: A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations

Schuler, Martin, Yang, James Chih-Hsin, Yamamoto, Nobuyuki, O’Byrne, Ken, Hirsh, Vera, Mok, Tony, Massey, Dan, Zazulina, Victoria, Shahidi, Mehdi, Sequist, Lecia

Journal:

Year:

2012

Language:

english

File:

PDF, 53 KB

english, 2012

23

New types of fluorine fibre

T. P. Krivorotenko, Z. A. Zazulina

Journal:

Fibre Chemistry

Year:

1974

Language:

english

File:

PDF, 83 KB

english, 1974

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски